Published in:
Open Access
01-12-2011 | Research
Hyaluronidase recruits mesenchymal-like cells to the lung and ameliorates fibrosis
Authors:
Claudia S Bitencourt, Priscilla AT Pereira, Simone G Ramos, Suely V Sampaio, Eliane C Arantes, David M Aronoff, Lúcia H Faccioli
Published in:
Fibrogenesis & Tissue Repair
|
Issue 1/2011
Login to get access
Abstract
Hyaluronidases (HYALs) comprise a group of enzymes that degrade hyaluronic acid (HA). In this report, we reveal that a single intranasal inoculation of HYAL induces an increase in mononuclear cells within the bronchoalveolar space demonstrating a mesenchymal-like phenotype, expressing stem cell antigen-1 (SCA-1), CD44 and CD73 but not CD34, CD45, CD3, CD4, CD8 or CD19. This influx of mesenchymal stem cell (MSC)-like cells was dependent on leukotriene production within the lung parenchyma. These findings prompted experiments demonstrating that HYAL treatment potently blocked bleomycin-induced lung injury and fibrosis while decreasing transforming growth factor (TGF)-β production and collagen deposition. These data suggest that HYAL is a novel and promising tool to use autologous MSC-like cells in the treatment of pulmonary fibrosis.